Hot Investor Mandate: Venture Firm Seeks New Investment Opportunities in Broad Life Sciences, with Strong Interests in Cardiovascular, Oncology, Neurology Indications

21 Nov

A venture capital firm with offices in the Bay Area and Western Europe manages over $230m investing in Life Sciences companies with a stage agnostic strategy. The initial investment size ranges from $0.5 million for seed stage companies to $5 million for later stages ventures, and reserves significant capital for follow on investments. The fund invests in Europe, US and Israel.

The firm is currently looking for new investment opportunities in therapeutics, medical devices, diagnostics and digital health with a focus on cardiovascular, oncology and neurology although they are opportunistic in other areas.

The firm seeks to invest in both private and public companies based in Europe, US and Israel.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: